Posted by Michael Wonder on 22 Jul 2023
Verrica Pharmaceuticals announces FDA approval of Ycanth (cantharidin) topical solution as the first FDA approved treatment of paediatric and adult patients with molluscum contagiosum
21 July 2023 - Ycanth is a drug-device combination product administered by a health care professional; Verrica plans to make Ycanth available by September 2023.
Verrica Pharmaceuticals today announced US FDA approval of Ycanth (cantharidin) topical solution for the treatment of molluscum contagiosum (molluscum) in adult and paediatric patients 2 years of age and older.
